CNN: The questions eating disorder experts have about weight loss medications
The University of Cincinnati's Susan McElroy, MD, spoke with CNN about the impact weight loss medications like semaglutide have on people with eating disorders. McElroy's research focuses on eating disorders, bipolar disorder and the cooccurrence of psychiatric illness with obesity.
Semaglutide, sold under brand names like Ozempic and Wegovy, are a kind of drug called glucagon-like peptide-1 receptor agonists or GLP-1 agonists. While originally prescribed for diabetes, semaglutide is becoming more and more popular for weight loss.
McElroy said there is little research on the connection between eating disorders and weight loss medications.
“I view eating disorders as the last frontier in psychiatry,” said McElroy, the Linda and Harry Fath endowed professor in the Department of Psychiatry & Behavioral Neuroscience in UC’s College of Medicine and chief research officer at the Lindner Center of HOPE. “The eating disorder field is hard because we’re just ignored.”
In general, medications that cause weight loss have a good chance to also reduce binge eating, McElroy said, but there currently isn't enough research into how to treat disorders like binge eating disorder with these medications.
“We desperately need more compounds to treat people with eating disorders,” McElroy said.
Featured photo at top of a semaglutide injection pen. Photo/aprott/iStock.
Related Stories
Enquirer: Experts discuss reasons for drop in overdose deaths
April 12, 2023
The University of Cincinnati's Christine Wilder, MD, spoke with the Cincinnati Enquirer about Hamilton County data that overdose deaths in 2022 dropped for the first time in six years.
U.S. News & World Report: Metformin may help young patients with bipolar disorder avoid weight gain
October 31, 2023
U.S. News & World Report highlighted recent research led by the University of Cincinnati and Northwell Health that found the drug metformin can help prevent or reduce weight gain in youth taking medication to treat bipolar disorder.
Cape Girardeau, Missouri news highlights UC clinical trial
February 20, 2024
KFVS-TV in Cape Girardeau, Missouri highlighted a University of Cincinnati clinical trial testing a wearable neurostimulation device to help patients with opioid use disorder and post-traumatic stress disorder stick with medication treatment while finding the right dose.
Cannabis Man podcast highlights UC researcher
May 5, 2022
The University of Cincinnati's LaTrice Montgomery was a guest on the Cannabis Man podcast to discuss the current state of cannabis research.
WCPO: UC expert, former police sergeant touring country to help stop veteran suicides
October 25, 2023
The University of Cincinnati's Kate Chard and former Cincinnati Police Department sergeant Dave Corlett spoke with WCPO about their work to prevent veteran suicides through training tied to workplace stress and PTSD in law enforcement and the veteran community.
Study: Strawberry consumption may reduce dementia risk for middle-aged individuals
November 2, 2023
New research from the University of Cincinnati found that daily strawberry consumption could help reduce the risk of dementia for certain middle-aged populations.
Is ketamine the answer to treatment-resistant depression?
May 16, 2024
The University of Cincinnati's Stephen Rush joined WVXU's Cincinnati Edition to discuss the use of ketamine and esketamine to treat treatment-resistant depression.
New York Times: Can A.I.-driven voice analysis identify mental disorders?
April 6, 2022
The University of Cincinnati's Dr. Maria Espinola was featured in a New York Times article about the role of artificial intelligence in identifying mental disorders through the sound of a patient's voice.
Reuters Health: Tablets tied to better use of VA mental health services
April 12, 2022
The University of Cincinnati's Kate Chard was featured in a Reuters Health article examining a study of video tablet telehealth mental health services for veterans.
55KRC: UC expert discusses ADHD
July 26, 2022
The University of Cincinnati's Jenni E. Farrow, MD, was featured in a segment on 55KRC's Simply Medicine program to discuss ADHD.